ArticleInternational journal of molecular sciences2026
The Mechanism of Whey Protein Hydrolysates with Oral Immunotolerance.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the mechanism of oral immune tolerance induced by whey protein hydrolysates, this study utilized five industrially used proteases to hydrolyze whey protein and prepared the hydrolysates. An oral immune tolerance model was established using Balb/c mice. The levels of specific IgG, IgE, and histamine in the serum of mice from the five hydrolysate-preventive groups were measured. The expression levels of genes and proteins associated with the MAPK signaling pathway in small intestinal mast cells were analyzed using qPCR and Western blot. The results demonstrated that the expression of JNK in the jejunum from the trypsin, bromelain, papain, Neutrase, and pepsin mouse groups was downregulated, which correlated with the alleviation of allergic responses. A moderate increase in ERK expression was accompanied by an expansion of Treg cells, thereby inducing oral immune tolerance. The process of oral immune tolerance was regulated by the MAPK signaling pathway. This study systematically elucidates the oral immune tolerance mechanisms of the five hydrolysates, and the conclusions will provide the guidance for the development of hypoallergenic infant formula.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.